There is a pattern in Web3 that we have all seen enough times.

A project launches.
The token comes first.
Incentives follow.
Users arrive because the rewards are attractive.

Then everyone waits for the business to appear.

Sometimes it does.

A lot of the time, it doesn’t.

That is why one line on the SL Labs website stood out to me:

“Powered by revenue, not promises.”

It sounds simple, but it points to a completely different way of building a Web3 economy.

Instead of using a token to finance the hope that a useful business eventually appears, SL Labs is trying to put an onchain economy on top of health infrastructure and services that already have real-world activity behind them.

That order matters.

One of crypto’s hardest problems is artificial demand.

A protocol launches a token, then needs people to want the token.

So it creates staking.

Then points.

Then multipliers.

Then liquidity incentives.

Then another reason to lock the token.

The system can become very sophisticated, but eventually you still have to ask:

Who needs this when the rewards stop?

That question is uncomfortable because a lot of Web3 activity is circular.

People use the product because there are rewards.
Rewards exist because the project needs users.
Users stay because they expect more rewards.

It can work for a while.

But incentives are not the same thing as demand.

SL Labs currently describes a different foundation.

Its wider ecosystem points to approximately 50,000 deployed CR scanners and 5,000 veterinary clinics, while its ECG research with Gachon University and Seoul National University Hospital covers more than 204,000 ECG segments. The site explicitly separates this existing parent-company traction from SL Labs itself rather than presenting everything as token-created growth.

That distinction is important.

It means the interesting question is no longer:

“How can we create activity around a token?”

It becomes:

“Can an onchain economic layer make existing activity more useful?”

That feels like a healthier place to start.

I think one of the best tests for any crypto project is ridiculously simple:

What does the token actually do?

Not what can you speculate on.

Not what can you stake.

What job does it perform inside the system?

SL Labs describes $SL as a service credit used to settle AI-service usage across its networks. Its website currently presents VetDental AI, MediReport, SL Watch and institutional data as different parts of one protocol, with AI-service usage creating credit demand.

That does not automatically guarantee success.

But at least the economic logic is understandable.

A service gets used.
A service requires a credit.
Usage creates demand for that credit.

There is something underneath the token.

And in Web3, that is more meaningful than it sounds.

Take VetDental AI as an example.

SL Labs describes it as an AI-assisted veterinary dental X-ray service connected to an existing network of veterinary clinics. The project currently labels it both a revenue engine and a credit sink.

This creates a very different mental model from a normal token incentive program.

The ideal loop is not:

token → rewards → users

It is closer to:

service → usage → revenue → settlement → protocol activity

That is the kind of loop I would rather see Web3 experiment with.

Because if the service remains useful, the economic activity has a reason to continue even after the novelty disappears.

Real-world assets and DePIN became huge narratives partly because crypto wanted something connected to actual economic activity.

But sometimes “real world” becomes another marketing label.

Owning hardware is not enough.

Having data is not enough.

Putting a transaction onchain is definitely not enough.

The harder test is whether something outside crypto would still have a reason to exist.

Would a clinic still want useful software?

Would someone still want a useful health report?

Would an AI service still solve a real workflow problem?

If yes, then blockchain can be added where it improves settlement, verification or coordination.

That order makes sense.

The real-world activity should justify the blockchain.

The blockchain should not have to justify the real-world activity.

THOR, the SL Labs Ambassador Hub, is obviously much more crypto-native.

Users can complete missions, check in, refer others and earn points through the community system.

Normally, I would look at a points hub and think:

“Okay, another engagement campaign.”

But the context changes when there is a larger product ecosystem behind it.

THOR can be the discovery layer.

People enter because missions are easy to understand.
Then they learn what SL Labs is building.
Some follow the products.
Some become more involved with the ecosystem.

That is a much better use of incentives than treating incentives as the product itself.

The campaign gets attention.

The underlying services have to earn retention.

Crypto is an industry built around future tense.

“We will build.”

“We will onboard.”

“We will partner.”

“We will generate revenue.”

There is nothing inherently wrong with a roadmap. Every project needs one.

But I increasingly prefer projects that can point to something that already happened.

SL Labs’ current website repeatedly emphasizes this idea of verifiable proof: deployed devices, clinic coverage, research data, live applications and existing business operations. It even explicitly says parent-company traction is labeled as such instead of being blurred into SL Labs traction.

I like that distinction.

Because credibility in Web3 often disappears when projects stretch every fact into a bigger claim.

Sometimes saying exactly what is real — and exactly what still needs to be proven — is more convincing.

None of this means SL Labs has already solved the problem.

It hasn’t.

Existing infrastructure does not guarantee that a new economic layer will succeed.

AI services still need users.

Users need to return.

Token demand needs to come from real usage rather than speculation.

Healthcare products face much higher standards than typical consumer crypto applications.

And SL Labs itself notes that SL Watch is currently a wellness product rather than a medical device, while medical-device functionality depends on regulatory clearance.

Those distinctions matter.

I would rather see a project acknowledge them than pretend the difficult parts are already finished.

For me, SL Labs is interesting because it is testing a different sequence.

Instead of:

token → capital → infrastructure → hopefully users

the ambition looks closer to:

infrastructure → services → users → economic layer

That second model is harder to hype.

But it may be easier to sustain.

Because when the token stops being the reason the ecosystem exists, the project has something else to fall back on:

utility.

And utility is still the hardest thing to manufacture in crypto.

Web3 has spent years proving that incentives can create activity.

We already know that.

The more important experiment now is whether Web3 can build economic layers around activity that would exist anyway.

That is why I think SL Labs is worth following.

Not because adding a token to healthcare automatically creates value.

But because putting an onchain economy after real infrastructure, real services and real usage is a much more interesting starting point than doing it the other way around.

Promises are easy.

Revenue is harder.

And in the long run, the harder thing may be the one that matters.

Explore SL Labs:

Join the THOR Ambassador Hub: